β-淀粉样蛋白免疫治疗阿尔茨海默型痴呆的研究进展
摘要
β-淀粉样蛋白免疫治疗阿尔茨海默型老年性痴呆是近年开展起来的新的研究领域。在阿尔茨海默病转基因动物上,β-淀粉样蛋白免疫治疗可抑制并改善脑的病理损害。尽管β-淀粉样蛋白疫苗在二期临床实验中发现了脑炎症状的病例,但这些病人的脑内确实有老年斑的减少。进一步的研究已部分揭示了β-淀粉样蛋白免疫治疗清除脑内β-淀粉样蛋白老年斑的机制及其产生副作用的原因。这些研究不仅为将来β-淀粉样蛋白免疫治疗重新回到临床打下了基础,也为其他的神经退行性疾病的治疗提供了新思路。
出处
《国外医学（老年医学分册）》
2005年第6期244-247,共4页
Foreign Medical Sciences(Geriatrics)
参考文献19
-
1Vehmas AK, Borchelt DR, Price DL et al. β - amyloid peptide vaccination results in marked changes in serum and brain Abeta levels in APPswe/PS1DeltaE9 mice, as detected by SELDI - TOF - based Protein Chip technology.DNA Cell Biol, 2001; 20 (11): 713～721.
-
2Oddo S, Billings L, Kesslak JP et al. Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron,2004; 43 (3): 321～332.
-
3Orgogozo JM, Gilman S, Dartigues JF et al. Subacute meningoencephalitis a subset of patients with AD after Ab42 immunization. Neurology, 2003; 61:46～54.
-
4Hock C, Konietzko U, Streffer JR et al. Antibodies against beta - amyloid slow cognitive decline in Alzheimer's disease. Neuron, 2003; 38:547～554.
-
5Ferrer I, Boada Povira M, Sanchez Guerra ML et al.Neuropathology and pathogenesis of encephalitis following amyloid- beta immunization in Alzheimer's disease. Brain Pathol, 2004; 14:11～20.
-
6Nicoll JA, Wilkinson D, Holmes C et al. Neuropathology of human Alzheimer disease after immunization with amyloid- beta peptide: a case report. Nat Med, 2003; 9:448～ 452.
-
7Lemere CA, Maron R, Selkoe DJ et al. Nasal vaccination with beta- amyloid peptide for the treatment of Alzheimer's disease. DNA Cell Biol, 2001; 20 (11):705～711.
-
8Dickey CA, Morgan DG, Kudchodkar S et al. Duration and specificity of humural immune responses in mice vaccinated with the Alzheimer's disease- associated beta - amyloid 1-42 peptide. DNA Cell Biol, 2001; 20 (11): 723～729.
-
9Bard F, Cannon C, Barbour R et al. Peripherally administered antilodies against amyloid beta - peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer' s disease. Nat Med, 2000; 6:916～ 920.
-
10DeMattos RB, Bales KR, Cummins DJ et al. Peripheral anti - A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer'sdisease. PNAS, 2001; 98:8850～8855.
-
1张艳莉,张苏明,张旻.Alzheimer病的实验动物模型[J].中国临床神经科学,2001,9(4):421-423. 被引量：5
-
2周保慧,李春红.31例阿尔茨海默型老年痴呆临床分析[J].中国民康医学,2003,15(11):677-678. 被引量：1
-
3宋春未,戴雪伶,姜招峰.阿尔茨海默病实验动物模型研究进展[J].生物学杂志,2013,30(5):85-88. 被引量：10
-
4黄义昆,梁建成.合用苯妥英钠对卡马西平血药浓度的影响[J].临床荟萃,2003,18(2):101-102.
-
5王敏（摘译）.α7受体与阿尔茨海默病相关[J].中华医学信息导报,2009,24(17):17-17.
-
6李占盟,马永萍.右额部脑胶质瘤误诊为老年性痴呆1例报告[J].河北精神卫生,1995,8(4):268-268.
-
7王玉凯,徐严明,刘焯霖,陶恩祥.帕金森病α-触核蛋白基因表达和转基因动物的研究进展[J].国外医学（神经病学．神经外科学分册）,2002,29(3):247-250.
-
8戴越盟.转基因动物在肝癌研究中的应用[J].普外基础与临床杂志,1997,4(3):182-184.
-
9杨建东,贺林.Alzheimer'S病的分子遗传学机制探究[J].世界科技研究与发展,1999,21(6):35-41.
-
10智孔亮,辛娜,曹志红,卢丽敏.细胞外基质金属蛋白酶诱导因子与阿尔茨海默病β-淀粉样蛋白的相关性研究[J].临床和实验医学杂志,2016,15(4):342-345. 被引量：2
